Olaparib in an ovarian cancer patient with end-stage renal disease and hemodialysis. Baum J, Zickler D, Bolbrinker J, Richter R, et al. Cancer Chemother Pharmacol 2023 Mar 22. doi: 10.1007/s00280-023-04514.

Read + Share

Amedeo Smart

Independent Medical Education

Baum J, Zickler D, Bolbrinker J, Richter R, et al. Olaparib in an ovarian cancer patient with end-stage renal disease and hemodialysis. Cancer Chemother Pharmacol 2023 Mar 22. doi: 10.1007/s00280-023-04514.
PMID: 36947209